As new treatments emerge, timely diagnosis helps match patients with the most appropriate care when it can have the greatest ...

The FDA cleared an artificial intelligence (AI)-powered wristband (Felix NeuroAI) to treat upper-limb functional limitations ...

Disrupted sleep appeared to reduce cortical thickness independently of Alzheimer's biomarkers, especially for women, a study ...

Some 25 years ago, a young Parkinson's disease investigator, Robert Hauser, MD, stepped to the podium at an American Academy ...

The American Academy of Neurology (AAN) has issued a position statement on therapies for neurological conditions that have ...

Mayo Clinic researchers have developed a new artificial intelligence (AI) tool that helps clinicians identify brain activity ...

The American Academy of Neurology issues new guidelines to help clinicians navigate the use of unproven neurologic therapies lacking FDA approval or strong evidence.

The annual meeting of the American Academy of Neurology (AAN) allows neurology experts from around the globe to share their latest clinical insights and expertise in patient care.

People living in more disadvantaged neighborhoods may be more likely to have biomarkers for inflammation and Alzheimer's ...